In addition, Sugiyama and colleagues demonstrated that the residual CCR4− eTreg cells and naive Tregs are sufficient to prevent deleterious autoimmunity when using anti-CCR4 mAb to decrease eTreg cells in the immune system [120]. The gene discussed is CCR4; the disease is Autoimmunity.